Pharos Capital Takes Majority Stake in RhythMedix

Strategic investment establishes a new platform for remote cardiac patient monitoring
NASHVILLE, Tenn - September 25, 2025 - Pharos Capital Group, LLC ("Pharos"), a middle-market private equity firm based in Dallas and Nashville, has acquired a majority stake in RhythMedix, a leading manufacturer and provider of remote cardiac monitoring systems and related services.

Founded in 2013, New Jersey-based RhythMedix was founded to improve the remote cardiac monitoring experience for both patients and clinicians. RhythmStar Registered , its proprietary offering, comprises the first wearable cardiac ECG monitor with a built-in 4G cellular connection. This design provides faster, more comfortable, and overall better arrhythmia detection without requiring additional devices.

According to Bob Crants III [https://bobcrants.com/], Founding Partner & Chief Investment Officer [https://www.linkedin.com/in/bobcrants] of the Pharos Capital Group, "This investment represents a significant step for us. We believe in RhythMedix's vision for the future of cardiac care."

This investment is the sixth from Pharos' latest flagship fund, investing in parallel alongside Pharos Capital Partners IV, L.P., which is a licensed Rural Business Investment Company.

Crants [https://www.instagram.com/bobcrants] heads Pharos Capital's $900 million+ healthcare portfolio. He leads the process of partnering with accomplished entrepreneurs to build companies that improve patient outcomes.Regarding Pharos Capital Group's overall strategy, Crants [https://x.com/bobcrants] said, "Our mission is to promote value-based care by lowering costs and expanding access, particularly within underserved communities."

About Pharos Capital Group

Based in Dallas and Nashville, Pharos Capital Group is a physician-founded investment firm focused on growing healthcare companies that aim to lower the total cost of care, improve patient outcomes and expand access to care in underserved markets. Since inception, Pharos has invested in 59 companies and has $1 billion of private equity assets under management as of September 30, 2023. Pharos typically invests $25-$50 million in rapidly growing middle market companies seeking later stage funding for internal growth, acquisitions, leveraged buyouts, management buyouts, or recapitalizations, predominantly across healthcare sectors.

For more information on Pharos, please visit www.pharosfunds.com [https://c212.net/c/link/?t=0&l=en&o=4060426-1&h=3992474473&u=http%3A%2F%2Fwww.pharosfunds.com%2F&a=www.pharosfunds.com]

Disclaimer: This press release may contain forward-looking statements. Forward-looking statements describe future expectations, plans, results, or strategies (including product offerings, regulatory plans and business plans) and may change without notice. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements.
Media Contact
Company Name: Pharos Capital Group
Contact Person: Media Relations
Email: Send Email [http://www.universalpressrelease.com/?pr=pharos-capital-takes-majority-stake-in-rhythmedix]
Country: United States
Website: http://www.pharosfunds.com

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. GetNews makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.